Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.
Varying the item format improved the range of measurement in patient-reported outcome measures assessing physical function.
Asymptomatic vivax malaria is associated with an IFN-?-program on adaptive immunity.
Vitiligo Pathogenesis and Emerging Treatments.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vitiligo Pathogenesis and Emerging Treatments.
Rashighi M, Harris JE. Vitiligo Pathogenesis and Emerging Treatments. Dermatol Clin. 2017 Apr; 35(2):257-265.
View in:
PubMed
subject areas
Adaptive Immunity
Antioxidants
Autoimmunity
Humans
Immunity, Innate
Immunosuppressive Agents
Melanocytes
Oxidative Stress
Phototherapy
Regeneration
Self Tolerance
T-Lymphocytes, Cytotoxic
Vitiligo
authors with profiles
John E Harris MD, PhD
Mehdi Rashighi Firoozabadi MD